In a court filing, Apple argues that China's ban on the sale of some iPhones, which it is appealing, would force it to settle its licensing battle with Qualcomm
Apple Inc. said a Chinese ban on the sale of some models of the iPhone will force it to settle a long and bitter licensing battle …
Context & Ripple Effects
The dispute has been escalating on two fronts since Qualcomm sued Apple in China in late 2017 seeking a sales and manufacturing ban, after separately preparing an ITC request to halt iPhone imports into the US. The decisive blow landed this week when a Chinese court issued a preliminary injunction blocking sale and import of the iPhone 6s through X over two Qualcomm patents.
Apple appealed, but today's filing concedes the strategic math: with its largest growth market partially closed to it, Apple says it would be forced to settle the licensing war it opened by accusing Qualcomm of an illegal business model.
First-order effects
- Apple must either win its appeal quickly or negotiate a settlement with Qualcomm while iPhone 6s-to-X sales remain enjoined in China — the filing itself is an admission of that leverage.
- Qualcomm converts a two-year royalty standoff into concrete bargaining power, having demonstrated it can restrict Apple's hardware sales rather than just litigate damages.
Second-order effects
- Qualcomm's parallel pressure points — the Chinese injunction and the threatened US import halt — now function as a coordinated squeeze, raising the cost to Apple of fighting on either front alone.
- Other handset makers watching the case see that patent holders can shop disputes across jurisdictions until one court blocks shipments, weakening every licensee's resolve to hold out on royalty terms.
Third-order effects
- If injunctions against product sales become a standard weapon in patent-licensing fights, licensing negotiations shift from courtroom damage calculations to market-access hostage-taking — favoring portfolio owners like Qualcomm over deep-pocketed licensees like Apple.
- Regulators and courts in major markets may face pressure to police the use of preliminary injunctions as negotiation leverage, since the alternative is companies settling under commercial duress rather than legal merit.
The trend: Patent-licensing wars are migrating toward whichever jurisdiction can actually block product sales, turning market access itself into the settlement lever.